GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (OTCPK:SRTOY) » Definitions » Cyclically Adjusted Book per Share

SRTOY (Sartorius Stedim Biotech) Cyclically Adjusted Book per Share : $1.96 (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Sartorius Stedim Biotech Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Sartorius Stedim Biotech's adjusted book value per share for the three months ended in Dec. 2024 was $4.290. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $1.96 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Sartorius Stedim Biotech's average Cyclically Adjusted Book Growth Rate was 27.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2025-04-02), Sartorius Stedim Biotech's current stock price is $20.96. Sartorius Stedim Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was $1.96. Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio of today is 10.69.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sartorius Stedim Biotech was 37.10. The lowest was 8.72. And the median was 16.98.


Sartorius Stedim Biotech Cyclically Adjusted Book per Share Historical Data

The historical data trend for Sartorius Stedim Biotech's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech Cyclically Adjusted Book per Share Chart

Sartorius Stedim Biotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1.24 1.69 1.96

Sartorius Stedim Biotech Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.69 1.73 1.81 2.03 1.96

Competitive Comparison of Sartorius Stedim Biotech's Cyclically Adjusted Book per Share

For the Medical Instruments & Supplies subindustry, Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio falls into.


;
;

Sartorius Stedim Biotech Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sartorius Stedim Biotech's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book= Book Value per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=4.29/127.0412*127.0412
=4.290

Current CPI (Dec. 2024) = 127.0412.

Sartorius Stedim Biotech Quarterly Data

Book Value per Share CPI Adj_Book
201212 0.555 97.957 0.720
201306 0.580 98.516 0.748
201312 0.641 99.356 0.820
201406 0.648 99.543 0.827
201412 0.712 99.543 0.909
201506 0.709 100.417 0.897
201512 0.758 99.717 0.966
201606 0.818 100.717 1.032
201612 0.867 101.217 1.088
201706 0.971 102.117 1.208
201709 0.000 102.717 0.000
201712 1.120 102.617 1.387
201803 0.000 102.917 0.000
201806 1.163 104.017 1.420
201809 1.225 104.718 1.486
201812 1.279 104.217 1.559
201903 1.283 104.217 1.564
201906 1.347 105.718 1.619
201909 1.395 106.018 1.672
201912 1.397 105.818 1.677
202003 1.471 105.718 1.768
202006 1.538 106.618 1.833
202009 1.721 105.818 2.066
202012 1.898 105.518 2.285
202103 1.977 107.518 2.336
202106 2.181 108.486 2.554
202109 2.129 109.435 2.472
202112 2.030 110.384 2.336
202203 2.298 113.968 2.562
202206 2.353 115.760 2.582
202209 2.442 118.818 2.611
202212 2.815 119.345 2.997
202303 2.812 122.402 2.919
202306 3.020 123.140 3.116
202309 3.005 124.195 3.074
202312 3.122 123.773 3.204
202403 4.280 125.038 4.349
202406 4.302 125.882 4.342
202409 4.451 126.198 4.481
202412 4.290 127.041 4.290

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Sartorius Stedim Biotech  (OTCPK:SRTOY) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=20.96/1.96
=10.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sartorius Stedim Biotech was 37.10. The lowest was 8.72. And the median was 16.98.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Sartorius Stedim Biotech Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius Stedim Biotech Business Description

Address
Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.

Sartorius Stedim Biotech Headlines

From GuruFocus

Q4 2021 Sartorius AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2022 Sartorius AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2020 Sartorius AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2022 Sartorius AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2022 Sartorius AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2020 Sartorius AG Earnings Call Transcript

By GuruFocus Research 02-14-2024